In vivo and in vitro lipidation of recombinant immunogens for direct iscom incorporation

Journal of Immunological Methods

Volumn 255, Issue 1-2, 2001, Pages 135-148

  Andersson, Christin ^a   Wikman, Maria ^a   Lövgren Bengtsson, Karin ^b   Lundén, Anna ^b   Ståhl, Stefan ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Affinity purification; Iscom; Lipid tagging; Subunit vaccine; Toxoplasma gondii

Indexed keywords

ANTIGEN; COPPER ION; FATTY ACID; GENE PRODUCT; HYBRID PROTEIN; ISCOM; LIPID; LIPOPROTEIN; MEMBRANE ANTIGEN; SURFACE ANTIGEN 1; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ESCHERICHIA COLI; EXPRESSION VECTOR; FEMALE; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUCROSE GRADIENT; ULTRACENTRIFUGATION;

ESCHERICHIA COLI; TOXOPLASMA GONDII;

EID: 0035452351     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(01)00430-6     Document Type: Article

References (41)

1. Tightly regulated tac promoter vectors useful for the expression of unfused and fused proteins in Escherichia coli
2. General expression vectors for production of hydrophobically tagged immunogens for direct iscom incorporation
3. Improved systems for hydrophobic tagging of recombinant immunogens for efficient iscom incorporation
4. The conformation of purified Toxoplasma gondii SAG1 antigen, secreted from engineered Pichia pastoris, is adequate for serorecognition and cell proliferation
5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
6. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii
7. A surface-displayed cholera toxin B peptide improves antibody responses using food-grade staphylococci for mucosal subunit vaccine delivery
8. Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunization using live staphylococci with surface-displayed RSV-peptides
9. A study on the isolation and characterisation of the saponin Quil A. Evaluation of its adjuvant activity with special reference to the application in foot-and-mouth disease
10. Purification and reconstitution into proteoliposomes of the F1F0 ATP synthase from the obligately anaerobic gram-positive bacterium Clostridium thermoautotrophicum
11. Nine amino acid residues at the NH2-terminal of lipoprotein are sufficient for its modification, processing, and localization in the outer membrane of Escherichia coli
12. Toxoplasma gondii infection in the mountain hare (Lepus timidus) and domestic rabbit (Orydactolagus cuniculus): I. Pathology
13. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits
14. Design and production of recombinant subunit vaccines
15. Recombinant Toxoplasma gondii surface antigen 1 (P30) expressed in Escherichia coli is recognized by human Toxoplasma-specific immunoglobulin M (IgM) and IgG antibodies
16. Genetic approach to facilitate purification of recombinant proteins with a novel metal chelate adsorbent
17. Conformationally appropriate expression of the Toxoplasma antigen SAG1 (P30) in CHO cells
18. A general bacterial expression system for functional analysis of cDNA-encoded proteins
19. High-throughput protein expression of cDNA products as a tool in functional genomics
20. Lipid-tagged antibodies: Bacterial expression and characterization of lipoprotein-single-chain antibody fusion protein
21. Functional immunoliposomes harboring a biosynthetically lipid-tagged single-chain antibody
22. Use of genetically engineered lipid-tagged antibody to generate functional europium chelate-loaded liposomes. Application in fluoroimmunoassay
23. The serum albumin-binding region of streptococcal protein G (BB) potentiates the immunogenicity of the G130-230 RSV-A protein
24. Production of recombinant subunit vaccines: Protein immunogens, live delivery systems and nucleic acid vaccines
25. Immune responses and resistance to Toxoplasma gondii in mice immunized with antigens of the parasite incorporated into immunostimulating complexes
26. The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes
27. Antigenic presentation of small molecules and peptides conjugated to a preformed iscom as carrier
28. Gene regulation at the right operator (OR) bacteriophage lambda. I. OR3 and autogenous negative control by repressor
29. Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses
30. Chromosomal sequencing using a PCR-based biotin-capture method allowed isolation of the complete gene for the outer membrane protein A of Klebsiella pneumoniae
31. Analysis and use of the serum albumin binding domains of streptococcal protein G
32. The use of Zwittergent 3-14 in the purification of recombinant human interferon-beta Ser17 (Betaseron)
33. pUR 250 allows rapid chemical sequencing of both DNA strands of its inserts
34. Specific protein attachment to artificial membranes via coordination to lipid-bound copper(II)
35. Immunogenicity in rabbits and monkeys of influenza ISCOMs conjugated with repeated sequences of the Plasmodium falciparum antigen Pf155/RESA
36. Induction of homologous virus neutralizing antibodies in guinea-pigs immunized with two human immunodeficiency virus type 1 glycoprotein gp120-iscom preparations. A comparison with other adjuvant systems
37. Vaccines: Subunit
38. A dual expression system for the generation, analysis and purification of antibodies to a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA
39. Affinity fusions, gene expression
40. Use of T7 RNA polymerase to direct expression of cloned genes
41. Influenza virus ISCOMs: Biochemical characterization